Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
18 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accord-biopharma-announces-commercial-launch-of-imuldosa-ustekinumab-srlf-prefilled-syringes-at-lowest-wac-price-among-branded-biosimilars-to-stelara-ustekinumab-302531289.html
14 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accord-biopharma-inc-announces-completion-of-udenyca-pegfilgrastim-cbqv-franchise-acquisition-from-coherus-biosciences-inc-expanding-us-biosimilar-portfolio-302427584.html
17 Mar 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761364
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-exclusive-commercialization-and-license-agreement-with-intas-pharmaceuticals-for-bat2506-a-proposed-biosimilar-referencing-simponi-golimumab-in-the-united-states-of-america-302372271.html
16 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/accord-biopharma-inc-recognizes-milestone-as-more-than-10-000-patients-gain-access-to-camcevi-leuprolide-302352332.html
23 Oct 2024
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-23-2024-21885.pdf
ABOUT THIS PAGE